Skip to content

Investigation of the effect of milk chocolate containing fructooligosaccharides on postprandial blood glucose levels.

Investigation of the effect of milk chocolate containing fructooligosaccharides on postprandial blood glucose levels. - Investigation of the effect of milk chocolate containing fructooligosaccharides on postprandial blood glucose levels.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041574
Enrollment
18
Registered
2020-08-28
Start date
2020-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy human

Interventions

Test food : ingestion of chocolate containing fructooligosaccharides with plain hot water . &gt
Control food : ingention of chocolate non-containing fructooligosaccharides with plain hot water. Control food : ingestion of chocolate non-containing fructooligosaccharides with plain hot water. &gt
Test food : ingention of chocolate containing fructooligosaccharides with plain hot water.

Sponsors

Niigata Bio-Research Park, Inc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who receive adequate explanation for the purpose and content of this trial and provide written informed consent for participation by their own free will. 2. Men and women over 30 years old. 3.Those with a fasting blood glucose level of less than 126 mg/dL and HbA1c of less than 6.5%. 4.Non smoker.

Exclusion criteria

Exclusion criteria: 1.Individuals with chronic disease medication. 2.Individuals who take medicines that may affect blood glucose metabolism, take foods for specified health use or foods with functional claims, at least 5 days a week. 3.Individuals with food allergies caused by cocoa, dairy ingredients, soy, eggs, wheat, shrimp, crab, peanuts, buckwheat, almonds, oranges, cashews, kiwifruits, walnuts ,sesame, bananas, peaches, apple, and gelatin. 4.Individuals aware of FOS intolerance. 5.Individuals who can not eat 60g of chocolate. 6.Men less than 40 kg and women less than 30 kg in weight. 7.Individuals comprehensively judged by the investigator to have distinct abnormalities in BMI, blood pressure, hematology test values, and biochemical test values in the preliminary test. 8.Individuals who are pregnant or breastfeeding. 9.Individuals who have participated in other clinical trials within one month before obtaining consent to participate in this study, or those who plan to participate in other clinical studies between the acquisition of consent to participate in this study and the end of the second examination. 10.Others who are judged to be inappropriate as subjects by the investigator.

Design outcomes

Primary

MeasureTime frame
Difference of area under the curve of blood glucose levels from baseline.

Secondary

MeasureTime frame
1.blood glucose levels (measured values, difference from baseline, area under the curve, Cmax, difference of Cmax of blood glucose levels from baseline, Tmax) 2.insulin levels (measured values, difference from baseline, area under the curve, difference of area under the curve of insulin levels from baseline, Cmax, difference of Cmax of insulin levels from baseline ,Tmax)

Countries

Japan

Contacts

Public ContactHiroshi Goto

Niigata Bio-Research Park, Inc Business promotion division

goto@nbrp.co.jp0250-25-1196

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026